Search Results - "Sudhakar, Akulapalli"

Refine Results
  1. 1

    Retraction Note: Inhibition of Tumor Angiogenesis by Tumstatin: Insights into Signaling Mechanisms and Implications in Cancer Regression by Sudhakar, Akulapalli, Boosani, Chandra S.

    Published in Pharmaceutical research (01-02-2021)
    “…A Retraction Note to this paper has been published: https://doi.org/10.1007/s11095-020-02974-x…”
    Get full text
    Journal Article
  2. 2

    Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing by Patil, Rohan, Das, Suranjana, Stanley, Ashley, Yadav, Lumbani, Sudhakar, Akulapalli, Varma, Ashok K

    Published in PloS one (16-08-2010)
    “…Weak intermolecular interactions such as hydrogen bonding and hydrophobic interactions are key players in stabilizing energetically-favored ligands, in an open…”
    Get full text
    Journal Article
  3. 3

    Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria by Sugimoto, Hikaru, Hamano, Yuki, Charytan, David, Cosgrove, Dominic, Kieran, Mark, Sudhakar, Akulapalli, Kalluri, Raghu

    Published in The Journal of biological chemistry (11-04-2003)
    “…There are about 2.5 million glomeruli in the kidneys each consisting of a barrel of glomerular basement membrane surrounded by glomerular endothelial cells on…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Characterization of the anti-angiogenic properties of arresten, an α1β1 integrin-dependent collagen-derived tumor suppressor by Nyberg, Pia, Xie, Liang, Sugimoto, Hikaru, Colorado, Pablo, Sund, Malin, Holthaus, Kathryn, Sudhakar, Akulapalli, Salo, Tuula, Kalluri, Raghu

    Published in Experimental cell research (01-11-2008)
    “…Physiological and pathological turnover of basement membranes liberates biologically active cryptic molecules. Several collagen-derived fragments possess…”
    Get full text
    Journal Article
  6. 6

    Function of Endogenous Inhibitors of Angiogenesis as Endothelium-Specific Tumor Suppressors by Sund, Malin, Hamano, Yuki, Sugimoto, Hikaru, Sudhakar, Akulapalli, Soubasakos, Mary, Yerramalla, Udaya, Benjamin, Laura E., Lawler, Jack, Kieran, Mark, Shah, Amish, Kalluri, Raghu, Folkman, Judah

    “…Disruption of the systemic angiogenesis balance to favor enhanced angiogenesis is speculated to represent a key step in the growth of tumors. Although a major…”
    Get full text
    Journal Article
  7. 7

    Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis by Maeshima, Yohei, Sudhakar, Akulapalli, Lively, Julie C., Ueki, Kohjiro, Kharbanda, Surender, Kahn, C. Ronald, Sonenberg, Nahum, Hynes, Richard O., Kalluri, Raghu

    “…Tumstatin is a 28-kilodalton fragment of type IV collagen that displays both anti-angiogenic and proapoptotic activity. Here we show that tumstatin functions…”
    Get full text
    Journal Article
  8. 8
  9. 9

    RETRACTED ARTICLE: Inhibition of Tumor Angiogenesis by Tumstatin: Insights into Signaling Mechanisms and Implications in Cancer Regression by Sudhakar, Akulapalli, Boosani, Chandra S.

    Published in Pharmaceutical research (01-12-2008)
    “…Growing tumors develop additional new blood vessels to meet the demand for adequate nutrients and oxygen, a process called angiogenesis. Cancer is a highly…”
    Get full text
    Journal Article
  10. 10

    Regulation of COX-2–mediated signaling by α3 type IV noncollagenous domain in tumor angiogenesis by Boosani, Chandra Shekhar, Mannam, Arjuna P., Cosgrove, Dominic, Silva, Rita, Hodivala-Dilke, Kairbaan M., Keshamouni, Venkateshwar G., Sudhakar, Akulapalli

    Published in Blood (15-08-2007)
    “…Human α3 chain, a noncollagenous domain of type IV collagen [α3(IV)NC1], inhibits angiogenesis and tumor growth. These biologic functions are partly attributed…”
    Get full text
    Journal Article
  11. 11

    Determinants of Vascular Permeability in the Kidney Glomerulus by Hamano, Yuki, Grunkemeyer, James A, Sudhakar, Akulapalli, Zeisberg, Michael, Cosgrove, Dominic, Morello, Roy, Lee, Brendan, Sugimoto, Hikaru, Kalluri, Raghu

    Published in The Journal of biological chemistry (23-08-2002)
    “…The human kidneys filter 70 liters of blood plasma every day. The hallmark of almost all kidney diseases, whether acquired or genetic, is the leakage of plasma…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Molecular Cloning and Functional Characterization of Mouse α3(IV)NC1 by Boosani, Chandra Shekhar, Sudhakar, Akulapalli

    Published in Clinical Medicine Insights. Oncology (01-01-2008)
    “…Chandra Shekhar Boosani1 and Akulapalli Sudhakar1,2,3 1Cell Signaling and Tumor Angiogenesis Laboratory, Department of Genetics, Boys Town National Research…”
    Get full text
    Journal Article
  14. 14

    Signaling Mechanisms of Endogenous Angiogenesis Inhibitors Derived from Type IV Collagen by Sudhakar, Akulapalli, Boosani, Chandra S.

    Published in Gene Regulation and Systems Biology (01-01-2007)
    “…Akulapalli Sudhakar1,2,3 and Chandra S. Boosani1 1Cell Signaling and Tumor Angiogenesis Laboratory, Department of Genetics, Boys Town National Research…”
    Get full text
    Journal Article Book Review
  15. 15

    Human Tumstatin and Human Endostatin Exhibit Distinct Antiangiogenic Activities Mediated by αvβ3 and α5β1 Integrins by Sudhakar, Akulapalli, Sugimoto, Hikaru, Yang, Changqing, Lively, Julie, Zeisberg, Michael, Kalluri, Raghu

    “…Tumstatin and endostatin are two inhibitors of angiogenesis derived from precursor human collagen molecules known as α3 chain of type IV collagen and α1 chain…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Inhibition of Tumor Angiogenesis by Tumstatin : Insights into Signaling Mechanisms and Implications in Cancer Regression by SUDHAKAR, Akulapalli, BOOSANI, Chandra S

    Published in Pharmaceutical research (01-12-2008)
    “…Growing tumors develop additional new blood vessels to meet the demand for adequate nutrients and oxygen, a process called angiogenesis. Cancer is a highly…”
    Get full text
    Journal Article
  18. 18

    Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin by Hamano, Yuki, Zeisberg, Michael, Sugimoto, Hikaru, Lively, Julie C, Maeshima, Yohei, Yang, Changqing, Hynes, Richard O, Werb, Zena, Sudhakar, Akulapalli, Kalluri, Raghu

    Published in Cancer cell (01-06-2003)
    “…We demonstrate a physiological role for tumstatin, a cleavage fragment of the α3 chain of type IV collagen (Col IVα3), which is present in the circulation…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Human α1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by α1β1 integrin by Sudhakar, Akulapalli, Nyberg, Pia, Keshamouni, Venkateshwar G., Mannam, Arjuna P., Li, Jian, Sugimoto, Hikaru, Cosgrove, Dominic, Kalluri, Raghu

    Published in The Journal of clinical investigation (08-09-2005)
    “…Human noncollagenous domain 1 of the α1 chain of type IV collagen [α1(IV)NC1], or arresten, is derived from the carboxy terminal of type IV collagen. It was…”
    Get full text
    Journal Article